ARDX Kidney Drug Passes Phase 3 Study, EDIT Up On CRISPR News, FDA Nod For VRX – Nasdaq
|
ARDX Kidney Drug Passes Phase 3 Study, EDIT Up On CRISPR News, FDA Nod For VRX
Nasdaq University of California (UC), Berkeley and Broad have been claiming that they were the first to invent the CRISPR technology and applied for a patent in March of 2013, and October of 2013, respectively. The Broad's patent was issued on April 15, 2014. |
